PAPIEŽ, Adriána, Klara ODEHNALOVA, Vladimír ŠRÁMEK a Pavel SUK. Comparison of Active Substance Losses and Total Weight Losses of Tablets Administered Via Feeding Tube. PHARMACOLOGY. BASEL: KARGER, 2019, roč. 103, 5-6, s. 246-249. ISSN 0031-7012. Dostupné z: https://dx.doi.org/10.1159/000496423.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Comparison of Active Substance Losses and Total Weight Losses of Tablets Administered Via Feeding Tube
Autoři PAPIEŽ, Adriána (703 Slovensko, domácí), Klara ODEHNALOVA (203 Česká republika), Vladimír ŠRÁMEK (203 Česká republika, domácí) a Pavel SUK (203 Česká republika, garant, domácí).
Vydání PHARMACOLOGY, BASEL, KARGER, 2019, 0031-7012.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30104 Pharmacology and pharmacy
Stát vydavatele Švýcarsko
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 1.625
Kód RIV RIV/00216224:14110/19:00109118
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1159/000496423
UT WoS 000464384500004
Klíčová slova anglicky Dosage forms; Drug administration routes; Nasogastric tube; Intensive care; High-pressure liquid chromatography
Štítky 14110122, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Tereza Miškechová, učo 341652. Změněno: 18. 12. 2019 14:26.
Anotace
Background/Aims: Administration of tablets via feeding tube (FT) is often associated with significant drug losses, as was confirmed by weighing. The aim of this study was to measure the proportion of active substance losses (ASLs) in an in vitro model. Methods: A film-coated tablet (FilmCT) containing clopidogrel (Trombex (R)) and a tablet with enteric coating (EntericCT) containing pantoprazole (Controloc (R)) were crushed in a mortar and transferred by method A (tablet powder was transferred into the beaker, poured into the syringe and water added) and method B (water was added into the mortar, suspension drawn into the syringe) and administered via FT in an in vitro model. Total losses were measured with analytical balance and, simultaneously, ASL were analyzed with high-performance liquid chromatography UV-detection (HPLC-UV). Results: ASL was different to weighing only in the case of EntericCT prepared by method B (2.0 +/- 4.2 and 10.7 +/- 0.8% for HPLC-UV and weighing, respectively; p = 0.004). HPLC-UV confirmed significantly lower ASL when method B was used for either EntericCT (34.3 +/- 7.2 vs. 2.0 +/- 4.2%; p < 0.001) or FilmCT (14.1 +/- 2.2 vs. 7.7 +/- 4.1%; p < 0.01). Conclusion: Drug loss analysis with analytical balance may overestimate ASL, as was proved for EntericCT in this study. ASL were significantly lower when method B was used.
VytisknoutZobrazeno: 8. 7. 2024 17:50